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Mannich aminomethylation of 8-methyl-7-hydroxy-2'-fluoroisoflavones applying bis-(N,N-
dimethylamino)methane afforded C-6 substituted N,N-dimethylaminomethyl derivatives. Subsequent 
acetylation of these compounds in acetic anhydride in the presence of potassium acetate provided 
access to the corresponding acetoxymethyl derivatives that were converted to hydroxymethyl- and 
alkoxymethyl-substituted 7-hydroxyisoflavonoids. Addition of 3-(N,N-dimethylamino)-5,5-
dimethyl-2-cyclohexen-1-one or 1,3-dimethyl-5-aminopyrazole with thermally generated ortho-
quinone methides led to hetero-Diels–Alder or Michael adducts. 
________________________________________________________________________________ 
Introduction 
It is widely known that the introduction of 
fluorine and fluorine-containing substituents into 
an organic molecule can significantly change the 
biological activity of the obtained compounds 
[1]. Since many of natural compounds are 
attractive for the development of new drugs [2], 
and chromones were recognized as a valid 
scaffold in medicinal chemistry [3], development 
of new isoflavone derivatives for potential 
biologically active compounds is of current 
interest. Moreover, the introduction of fluorine-
containing groups into ring B of isoflavones is 
also of undoubted interest. Thus, it was shown 
that A- or B-ring fluorinated isoflavones exhibit 
diverse biological activity, and can be useful in 
the search process of new drugs. [4-10]. Among 
the reactions of isoflavone derivatives that lead 
to skeleton modification, the well-known 
tendency of phenolic substrates to enter Mannich 
condensation by interactions with formaldehyde 
and amines should be mentioned. This method is 
promising for the modification of previously 
obtained fluorinated derivatives. Thus, it was 
shown that the interaction of 4'-fluoro-7-
hydroxyisoflavones with primary aliphatic 
amines and formaldehyde in the presence of a 
catalytic amount of DMAP produces 3-(4-
fluorophenyl)-9,10-dihydro-4H,8H-chromeno 
derivatives[8,7-e][1,3]oxazin-4-one [11]. Such 
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reactions are characteristic for 5-
hydroxychromones, 7-hydroxychromones and 8-
hydroxychromones. Thus, aminomethylation of 
5,7-dihydroxychromones usually gave mixtures 
of 6- and 8-aminomethyl derivatives, where, in 
some cases, 6-aminomethyl derivatives were the 
major products, unless the formation of 8 
substituted regioisomers was observed [12]. It 
was reported that such transformations may be 
regiospecific and regioselective. For instance, 
regiospecific Mannich aminomethylation of 7-
hydroxyisoflavonoids using bis-(N,N-
dimethylamino)methane afforded C-8 
substituted N,N-dimethylaminomethyl adducts, 
while the regioselective aminomethylation of 5-
hydroxy-7-methoxyisoflavonoids afforded 
predominant N,N-dimethylaminomethyl adducts 
[13]. In this work methods for obtaining 6-
aminomethyl derivatives of 7-hydroxy-2-
fluoroisoflavones were developed, and their 
subsequent transformations were designed for 
the synthesis of isoflavones with biologically 
attractable substituents. 
Results and discussion 
The main strategy for the construction of 
isoflavones includes synthesis of hydroxylated 
diaryl ethanones (using Houben-Hoesch reaction 
[14] or Friedel-Crafts acylation of phenols [15]) 
with subsequent ring-closure reaction. The 
starting compound for the synthesis of B-ring 
fluorinated isoflavones deoxybenzoin 1 was 
prepared by reacting 2-methylresorcinol with (2-
fluorophenyl)acetonitrile in boron trifluoride 
etherate medium with gaseous HCl, followed by 
treatment with water. Then, 1 was subjected to an 
intramolecular cyclization reaction in the 
presence of phosphorous oxytrichloride in 
solution of N,N-dimethylformamide or N,N-
dimethylacetamide yielded 7-
hydroxyisoflavones 2a and 2b. Subsequent 
aminomethylation reaction of compounds 2 with 
the twofold excess of bis-(N,N-
dimethylamino)methane in 1,4-dioxane at reflux 
affords in the 6-(dimethylamino)methyl 
derivatives 3a and 3b (Scheme 1).  
 
Scheme 1. Synthesis of 2'-fluoroisoflavones and their 6-aminomethyl derivatives. 
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The direct conversion of N,N-
dimethylaminomethyl derivatives 3 into the 
corresponding diacetoxy derivatives 4 easily 
proceeded with good yields in acetic anhydride 
with presence of potassium acetate. Hydrolysis 
of such diacetates 4 in dioxane in the presence of 
0.2 M aqueous sulfuric acid under moderate 
heating resulted in 7-hydroxy-6-hydroxymethyl 
derivatives 5a and 5b (Scheme 2). In case of 
using of methanol or ethanol as solvent for the 
deacetylation, the formation of 7-hydroxy-6-
akkoxymethyl isoflavones 6 or 7 was observed. 
 
Scheme 2. Synthesis of 2'-fluoroisoflavone 6-hydroxy/alkoxymethyl derivatives. 
 
As we previously reported, 7-hydroxy-8-
dimethylaminomethyl/alkoxymethyl isoflavone 
[16] and phenol [17] derivatives may be used as 
precursors for the thermally generated ortho-
quinone methides.  
 
 
Scheme 3. Appling of 2'-fluoroisoflavones 3b or 6a in Diels-Alder reaction and Michael addition.
We expected that synthesized 2'-
fluoroisoflavone Mannich bases and 6-
alkoxymethyl derivatives also can thermally 
generate ortho-quinone methides 8a or 8b. For 
the trapping of these intermediates we used 3-
(N,N-dimethylamino)-5,5-dimethylcyclohex-2-
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en-1-one (9) such as related derivatives of 6-
dimethelaminomethyl isoflavones shown 
promise anticancer activity [16]. The reaction of 
Mannich base 3b with enaminone 10 led to the 
formation of tetracyclic compound 10 via 
formation of ortho-quinone methide 8b, inverse-
electron-demand Diels–Alder addition with 
compound 9, and resulting elimination of 
dimethylamine from hetero-Diels-Alder adduct, 
which afford compond 10.  
Using of electron-rich 5-amino-1,3-
dimethylpyrazole (11) for the trapping of 
thermally generated from methoxymethil 
derivative 6a ortho-quinone methide 9a, led to 
the Michael adduct 12 appearance. It should be 
noted, that reaction was carried out on pyrazole 
C-4 atom, instead involving of 5-aminogroup 
(Scheme 3). Such result may be explained by 
presence of the coordinated electron-donating 
effects of pyrazole ring and 5-aminogroup. 
 
Conclusions 
Simple synthetic methods for the 
introduction of hydroxymethyl/methoxymethyl 
group on position 6 of chromone ring have been 
developed for the B-ring fluorine-containing 7-
hydroxyisoflavones. Reaction of the thermally 
generated ortho-quinone methides with 3-(N,N-
dimethylamino)-5,5-dimethyl-2-cyclohexen-1-
one or 1,3-dimethyl-5-aminopyrazole led to the 
formation of hetero-Diels–Alder or Michael 
products. Synthesized fluorinated isoflavones 
could be useful for the further studies of their 
anticancer activity.  
Experimental part 
General 
Melting points were determined in open 
capillarity tubes with a Buchi B-535 apparatus. 
Reaction completion and chemical purity of the 
synthesized compounds were controlled by TLC 
with Macherey-Nagel ALUGRAM Xtra Sil 
G/UV254 plates. Column chromatography was 
performed using Macherey-Nagel Silica 60, 
0.04-0.063 mm silica gel. 1H, 13C and 19F NMR 
spectra were recorded on a Bruker Avance 500 
spectrometer or on a Varian 400 spectrometer in 
CDCl3 or DMSO-d6 [residual CHCl3 (δH = 7.26 
ppm) or CDCl3 (δC = 77.16 ppm) as internal 
reference] or in DMSO-d6 [residual 
SO(CD3)(CD2H)3 (δH = 2.50 ppm) or SO(CD3)2 
(δC = 39.52 ppm) as internal reference]. CFCl3 (δF 
= 0.00 ppm) was used external reference for 19F 
NMR spectra. LC/MS (APCI) spectra were 
recorded on Agilent 1100 LC MS (APCI) SL 
instrument, column SUPELCO Ascentis Express 
C18. 
1-(2,4-Dihydroxy-3-methylphenyl)-2-(2-
fluorophenyl)ethanone (1). A solution of 13.6 g 
(0.11 mol) 2-methylresorcinol, 13.5 g (0.1 mol) 
of the (2-fluorophenyl)acetonitrile in 80 mL of 
boron trifluoride etherate was saturated by 
bubbling of gaseous dry HCl over a 6h period at 
ambient temperature. The mixture was poured 
into 500 mL of water at 80oC. Then, the resulting 
mixture was heated to reflux for 2h, cooled to 
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ambient temperature. The formed solid was 
filtered off and recrystallized from mixture of 
MeOH-H2O. Yield: 15.0 g (58%); white solid; 
m.p. 150 – 152 oC. 1H NMR (400 MHz, DMSO-
d6): δ 12.80 (s, 1H), 10.64 (s, 1H), 7.82 (d, J = 
8.9 Hz, 1H), 7.41 – 7.27 (m, 2H), 7.24 – 7.05 (m, 
2H), 6.54 (d, J = 8.9 Hz, 1H), 4.40 (s, 2H), 2.00 
(s, 3H) ppm. 13C NMR (125 MHz, DMSO-d6): δ 
200.92, 162.83, 162.47, 160.81 (d, J(C,F) = 244.3 
Hz), 132.33 (d, J(C,F) = 4.6 Hz), 129.72, 128.94 
(d, J(C,F) = 8.1 Hz), 124.26 (d, J(C,F) = 3.3 Hz), 
122.36 (d, J(C,F) = 16.1 Hz), 115.00 (d, J(C,F) = 
21.5 Hz), 111.60, 110.48, 107.43, 37.73, 7.59 
ppm. 19F NMR (376 MHz, DMSO-d6): δ -116.7 
ppm. MS (APCI): calcd for C15H14FO3+ [M+H]+: 
261.1 m/z, found: 261.2 m/z. 
3-(2-Fluorophenyl)-7-hydroxy-8-
methyl-4H-chromen-4-one (2a). To a solution 
of 1.3 g (0.05 mol) deoxybenzoin 1 in 10 mL of 
N,N-dimethylformamide at 30-40 OC boron 
trifluoride etherate (1.9 mL, 0.15 mol) was 
added. After the mixture was stirred for 0.5 h, the 
phosphorous oxytrichloride (1.86 mL, 0.1 mol) 
was added at the same temperature. The mixture 
was heated at 55-60OC for 2 h than was poured 
into 50 mL of boilling water with vigorous 
stirring and then cooled. The formed precipitate 
was filtered off, washed with water and 
recrystallized from methanol. Yield: 0.99g, 
(73%) white solid; m.p. 287 – 289 oC. 1H NMR 
(400 MHz, DMSO-d6): δ 10.73 (s, 1H), 8.41 (s, 
1H), 7.82 (d, J = 8.7 Hz, 1H), 7.55 – 7.39 (m, 
2H), 7.32 – 7.22 (m, 2H), 7.03 (d, J = 8.7 Hz, 
1H), 2.24 (s, 3H) ppm. 13C {1H} NMR (125 
MHz, DMSO-d6): δ 174.09, 160.25, 160.12 (d, 
J(C,F) = 246.5 Hz), 155.67, 154.68 , 132.24 (d, 
J(C,F) = 3.3 Hz), 130.17 (d, J(C,F) = 8.2 Hz), 124.17 
(d, J(C,F) = 3.2 Hz), 123.70, 120.12 (d, J(C,F) = 15.6 
Hz), 119.15, 116.37, 115.41 (d, J(C,F) = 21.9 Hz), 
114.12, 111.15, 7.98 ppm. 19F {1H} NMR (376 
MHz, DMSO-d6): δ -114.8 ppm. MS (APCI): 
calcd for C16H12FO3+ [M+H]+: 271.1 m/z, found: 
271.0 m/z. 
3-(2-Fluorophenyl)-7-hydroxy-2,8-dimethyl-
4H-chromen-4-one (2b). To a solution of 1.3 g 
(0.05 mol) deoxybenzoin 1 in 10 mL of N,N-
dimethylacetamide at 30-40 OC boron trifluoride 
(1.9 mL, 0.15 mol) was added. After the mixture 
was stirred for 0.5 h, the phosphorous 
oxytrichloride (1.86 mL, 0.1 mol) was added at 
the same temperature. The mixture was heated at 
55-60OC for 6-8 h, than was poured into 50 mL 
of hot water with vigorous stirring and then 
cooled. The formed precipitate was filtered off, 
washed with water and recrystallized from 
methanol. Yield: 0.80 g, (56%); pale yellow 
powder; m.p. 321 – 323 oC. 1H NMR (400 MHz, 
DMSO-d6): δ 10.62 (s, 1H), 7.72 (d, J = 8.7 Hz, 
1H), 7.45 – 7.37 (m, 1H), 7.34 – 7.28 (m, 1H), 
7.27 – 7.20 (m, 2H), 6.96 (d, J = 8.7 Hz, 1H), 
2.21 (s, 3H), 2.20 (s, 3H) ppm. 13C {1H} NMR 
(125 MHz, DMSO-d6): δ 174.59, 163.17, 160.09, 
159.89 (d, J(C,F) = 244.6 Hz), 155.18, 132.78 (d, 
J(C,F) = 3.4 Hz), 130.07 (d, J(C,F) = 8.2 Hz), 124.20 
(d, J(C,F) = 3.5 Hz), 123.51, 121.13 (d, J(C,F) = 16.5 
Hz), 116.28, 115.39 (d, J(C,F) = 22.0 Hz), 115.20, 
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113.73, 110.75, 18.92, 7.93 ppm. 19F {1H} NMR 
(376 MHz, CDCl3): δ -113.8 ppm. MS (APCI): 
calcd for C17H14FO3+ [M+H]+: 285.1 m/z, found: 
285.2 m/z. 
General procedure for the synthesis of 
Mannich bases 3a, 3b. To a suspension of 5 
mmol of isoflavone 2a or 2b in 30 mL of 1,4-
dioxane, 1.4 mL (10 mmol) of bis(N,N-
dimethylamino)methane at 70oC was added. The 
mixture was heated at 100oC for 16 h, cooled, and 
diluted with hexane. The formed precipitate was 
collected to afford Mannich bases of 3a, 3b.  
6-[(Dimethylamino)methyl]-3-(2-
fluorophenyl)-7-hydroxy-8-methyl-4H-
chromen-4-one (3a). Yield: 1.51 g (92%); white 
solid; m.p. 149 – 151 oC. 1H NMR (400 MHz, 
CDCl3): δ 8.03 (s, 1H), 7.82 (s, 1H), 7.52 – 7.45 
(m, 1H), 7.41 – 7.33 (m, 1H), 7.25 – 7.13 (m, 
2H), 3.79 (s, 2H), 2.37 (s, 6H), 2.33 (s, 3H) ppm. 
13C {1H} NMR (125 MHz, CDCl3): δ 175.48, 
161.65, 160.40 (d, J(C,F) = 247.6 Hz), 155.86, 
154.03 (d, J(C,F) = 2.7 Hz), 132.15 (d, J(C,F) = 2.6 
Hz), 129.87 (d, J(C,F) = 8.2 Hz), 124.03 (d, J(C,F) 
= 3.3 Hz), 122.80, 120.56, 120.02 (d, J(C,F) = 14.9 
Hz), 119.43, 116.59, 115.82 (d, J(C,F) = 22.3 Hz), 
112.07, 62.40, 44.26, 7.90 ppm. 19F {1H} NMR 
(470 MHz, CDCl3): δ -114.8 ppm. MS (APCI): 
calcd for C19H19FNO3+ [M+H]+: 328.1 m/z, 
found: 328.2 m/z. 
6-[(Dimethylamino)methyl]-3-(2-
fluorophenyl)-7-hydroxy-2,8-dimethyl-4H-
chromen-4-one (3b). Yield: 1.49 g (87%); beige 
solid; m.p. 177 – 179 oC. 1H NMR (400 MHz, 
CDCl3): δ 7.73 (s, 1H), 7.39 – 7.32 (m, 1H), 7.31 
– 7.27 (m, 1H), 7.23 – 7.18 (m, 1H), 7.17 – 7.11 
(m, 1H), 3.76 (s, 2H), 2.35 (s, 6H), 2.32 (s, 3H), 
2.29 (s, 3H) ppm. 13C {1H} NMR (100 MHz, 
CDCl3): δ 176.28, 163.49, 161.43, 160.43 (d, 
J(C,F) = 246.1 Hz), 155.58, 132.80 (d, J(C,F) = 3.3 
Hz), 129.91 (d, J(C,F) = 8.2 Hz), 124.12 (d, J(C,F) 
= 3.5 Hz), 122.78, 121.29 (d, J(C,F) = 16.5 Hz), 
120.20, 116.93, 115.84 (d, J(C,F) = 22.3 Hz), 
115.47, 111.71, 62.52, 44.37, 19.44, 8.01 ppm. 
19F {1H} NMR (376 MHz, CDCl3): δ -115.2 
ppm. MS (APCI): calcd for C20H21FNO3+ 
[M+H]+: 342.2 m/z, found: 342.2 m/z. 
General procedure for the synthesis of 
diacetates 4a, 4b. A mixture of a Mannich base 
3a or 3b (2 mmol) and 200 mg (2 mmol) of 
potassium acetate in 5 mL of acetic anhydride 
was refluxed for 5 min and cooled to room 
temperature. The mixture was diluted with water 
to form a precipitate of 5a,b respectively, which 
was recrystallized from acetonitrile-water. 
[7-(Acetyloxy)-3-(2-fluorophenyl)-8-methyl-
4-oxo-4H-chromen-6-yl]methyl acetate (4a). 
Yield: 365 mg (95%); white solid; m.p. 120 – 122 
oC. 1H NMR (400 MHz, CDCl3): δ 8.22 (s, 1H), 
8.08 (s, 1H), 7.46 (t, J = 7.4 Hz, 1H), 7.41 – 7.31 
(m, 1H), 7.24 – 7.08 (m, 2H), 5.13 (s, 2H), 2.39 
(s, 3H), 2.29 (s, 3H), 2.07 (s, 3H) ppm. 13C {1H} 
NMR (125 MHz, CDCl3): δ 175.12, 170.52, 
168.17, 160.29 (d, J(C,F) = 248.0 Hz), 155.12, 
154.63, 154.61, 151.53, 132.00 (d, J(C,F) = 2.8 
Hz), 130.31 (d, J(C,F) = 8.2 Hz), 126.65, 125.16, 
124.15 (d, J(C,F) = 3.5 Hz), 122.30, 121.39, 
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120.31, 119.17 (d, J(C,F) = 14.8 Hz), 115.90 (d, 
J(C,F) = 22.2 Hz), 61.31, 20.83, 20.50, 9.48 ppm. 
19F {1H} NMR (376 MHz, CDCl3): δ -114.7 
ppm. MS (APCI): calcd for C21H18FO6+ [M+H]+: 
385.1 m/z, found: 385.0 m/z. 
 [7-(Acetyloxy)-3-(2-fluorophenyl)-2,8-
dimethyl-4-oxo-4H-chromen-6-yl]methyl 
acetate (4b). Yield: 371 mg (93%); white solid; 
m.p. 144 – 146 oC. 1H NMR (400 MHz, CDCl3): 
δ 8.15 (s, 1H), 7.40 – 7.32 (m, 1H), 7.30 – 7.24 
(m, 1H), 7.23 – 7.17 (m, 1H), 7.13 (t, J = 8.9 Hz, 
1H), 5.11 (s, 2H), 2.38 (s, 3H), 2.31 (s, 3H), 2.29 
(s, 3H), 2.06 (s, 3H) ppm. 13C {1H} NMR (125 
MHz, CDCl3): δ 175.63, 170.45, 168.16, 164.34, 
160.21 (d, J(C,F) = 246.6 Hz), 154.78, 151.32, 
132.50 (d, J(C,F) = 3.0 Hz), 130.18 (d, J(C,F) = 8.2 
Hz), 126.12, 125.04, 124.12 (d, J(C,F) = 3.4 Hz), 
121.07, 120.81, 120.40 (d, J(C,F) = 16.3 Hz), 
117.81, 115.78 (d, J(C,F) = 22.1 Hz), 61.31, 20.79, 
20.47, 19.35, 9.44 ppm. 19F {1H} NMR (376 
MHz, CDCl3): δ -114.8 ppm. MS (APCI): calcd 
for C22H20FO6+ [M+H]+: 399.1 m/z, found: 399.0 
m/z. 
General procedures for the synthesis of 
hydroxymethyl derivatives 5a, 5b. A solution 
of compound 4a, 4b (1 mmol) in 10 mL of 1,4-
dioxane and 20 mL of 0.2 M aqueous sulfuric 
acid was heated at 50-60oC for 6-8 h. The mixture 
was cooled and diluted with 30 mL water, the 
resulting precipitate was filtered off. The crude 
product was chromatographed using 1:20 
methanol-dichloromethane mixture as eluent to 
afford 6a,b, recrystallized from acetonitrile. 
3-(2-Fluorophenyl)-7-hydroxy-6-
(hydroxymethyl)-8-methyl-4H-chromen-4-
one (5a). Yield: 150 mg (50%); white solid; m.p. 
177 – 179 oC. 1H NMR (400 MHz, DMSO-d6): δ 
9.80 (s, 1H), 8.44 (s, 1H), 7.94 (s, 1H), 7.54 – 
7.37 (m, 3H), 7.34 – 7.17 (m, 2H), 4.64 (s, 2H), 
2.30 (s, 3H). 13C {1H} NMR (125 MHz, DMSO-
d6): δ 174.16, 160.13 (d, J(C,F) = 246.4 Hz), 
157.25, 154.66, 154.52, 132.27, 130.20 (d, J(C,F) 
= 8.0 Hz), 128.33, 124.24, 120.75, 120.21 (d, 
J(C,F) = 15.6 Hz), 119.26, 116.32, 115.46 (d, J(C,F) 
= 21.9 Hz), 111.39, 59.07, 8.46 ppm. 19F {1H} 
NMR (470 MHz, DMSO-d6): δ -113.7 ppm. MS 
(APCI): calcd for C17H14FO4+ [M+H]+: 301.1 
m/z, found: 301.2 m/z. 
3-(2-Fluorophenyl)-7-hydroxy-6-
(hydroxymethyl)-2,8-dimethyl-4H-chromen-
4-one (5b). Yield: 176 mg (56%); white solid; 
m.p. 186 – 188 oC. 1H NMR (400 MHz, DMSO-
d6): δ 9.69 (s, 1H), 7.86 (s, 1H), 7.52 – 7.38 (m, 
1H), 7.38 – 7.19 (m, 3H), 5.43 (s, 1H), 4.64 (s, 
2H), 2.31 (s, 3H), 2.25 (s, 3H) ppm. 13C {1H} 
NMR (125 MHz, DMSO-d6): δ 174.64, 163.12, 
159.87 (d, J(C,F) = 244.5 Hz), 157.06, 154.01, 
132.77, 130.10 (d, J(C,F) = 8.1 Hz), 127.88, 
124.24, 121.18 (d, J(C,F) = 16.5 Hz), 120.63, 
116.40, 115.43 (d, J(C,F) = 21.9 Hz), 115.11, 
111.01, 59.04, 19.00, 8.41 ppm. 19F {1H} NMR 
(470 MHz, DMSO-d6): δ -113.6 ppm. MS 
(APCI): calcd  for C18H16FO4+ [M+H]+: 315.1 
m/z, found: 315.2 m/z. 
General procedures for the synthesis of 
alkoxymethyl derivatives 6 – 7. A mixture of 
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diacetate 4a or 4b (2 mmol) and 0.1 mL of 
concentrated hydrochloric acid in 10 mL of 
methanol or ethanol was refluxed for 16-24 h. 
The mixture was cooled and diluted with water, 
the resulting precipitate was filtered off. The 
products 6a,b and 7a,b were purified by column 
chromatography using 1:20 methanol-
dichloromethane mixture as eluent. 
3-(2-Fluorophenyl)-7-hydroxy-6-
(methoxymethyl)-8-methyl-4H-chromen-4-
one (6a). Yield: 242 mg (77%); white solid; m.p. 
143 – 145 oC. 1H NMR (500 MHz, DMSO-d6): δ 
9.79 (s, 1H), 8.40 (s, 1H), 7.86 (s, 1H), 7.57 – 
7.35 (m, 2H), 7.25 (q, J = 7.4, 6.9 Hz, 2H), 4.52 
(s, 2H), 3.34 (s, 3H), 2.28 (s, 3H) ppm. 13C {1H} 
NMR (125 MHz, DMSO-d6): δ 174.07, 160.09 
(d, J(C,F) = 246.4 Hz), 157.52, 154.83, 154.72, 
132.22, 130.20 (d, J(C,F) = 8.0 Hz), 124.62, 
124.18, 122.21, 120.08 (d, J(C,F) = 15.6 Hz), 
119.25, 116.28, 115.42 (d, J(C,F) = 21.9 Hz), 
111.82, 69.13, 57.79, 8.55 ppm. 19F {1H} NMR 
(470 MHz, DMSO-d6): δ -113.46 ppm. 19F {1H} 
NMR (470 MHz, CDCl3): δ -113.5 ppm. MS 
(APCI): calcd for C18H16FO4+ [M+H]+: 315.1 
m/z, found: 315.2 m/z. 
3-(2-Fluorophenyl)-7-hydroxy-6-
(methoxymethyl)-2,8-dimethyl-4H-chromen-
4-one (6b). Yield: 256 mg (78%); white solid; 
m.p. 159 – 161 oC. 1H NMR (500 MHz, DMSO-
d6): δ 9.67 (s, 1H), 7.79 (s, 1H), 7.46 – 7.39 (m, 
1H), 7.34 – 7.21 (m, 3H), 4.51 (s, 2H), 3.33 (s, 
3H), 2.30 (s, 3H), 2.22 (s, 3H) ppm. 13C {1H} 
NMR (125 MHz, DMSO-d6): δ 174.59, 163.25, 
159.88 (d, J(C,F) = 244.7 Hz), 157.40, 154.37, 
132.77 (d, J(C,F) = 3.0 Hz), 130.10 (d, J(C,F) = 8.2 
Hz), 124.23 (d, J(C,F) = 3.0 Hz), 124.17, 122.17, 
121.09 (d, J(C,F) = 16.5 Hz), 116.42, 115.42 (d, 
J(C,F) = 22.0 Hz), 115.12, 111.45, 69.18, 57.74, 
18.94, 8.51 ppm. 19F {1H} NMR (470 MHz, 
DMSO-d6): δ -113.7 ppm. MS (APCI): calcd for 




Yield: 250 mg (76%); white solid; m.p. 136 – 138 
oC. 1H NMR (500 MHz, DMSO-d6): δ 9.77 (s, 
1H), 8.41 (s, 1H), 7.87 (s, 1H), 7.48 – 7.38 (m, 
2H), 7.29 – 7.21 (m, 2H), 4.56 (s, 2H), 3.54 (q, J 
= 6.8 Hz, 2H), 2.29 (s, 3H), 1.17 (d, J = 6.8 Hz, 
3H) ppm. 13C {1H} NMR (125 MHz, DMSO-d6): 
δ 174.50, 160.52 (d, J(C,F) = 246.4 Hz), 157.88, 
155.19, 155.16, 132.65 (d, J(C,F) = 3.1 Hz), 
130.63 (d, J(C,F) = 8.2 Hz), 125.42, 124.62 (d, 
J(C,F) = 3.1 Hz), 122.43, 120.52 (d, J(C,F) = 15.6 
Hz), 119.68, 116.72, 115.85 (d, J(C,F) = 21.9 Hz), 
112.18, 67.58, 65.77, 15.56, 8.98 ppm. 19F {1H} 
NMR (470 MHz, DMSO-d6): δ -113.5 ppm. MS 
(APCI): calcd for C19H18FO4+ [M+H]+: 329.1 
m/z, found: 329.0 m/z. 
6-(Ethoxymethyl)-3-(2-fluorophenyl)-7-
hydroxy-2,8-dimethyl-4H-chromen-4-one 
(7b). Yield: 284 mg (83%); white solid; m.p. 146 
– 148 oC. 1H NMR (400 MHz, DMSO-d6): δ 9.67 
(s, 1H), 7.81 (s, 1H), 7.45 (d, J = 6.1 Hz, 1H), 
7.38 – 7.18 (m, 3H), 4.57 (s, 2H), 3.55 (d, J = 6.9 
Hz, 2H), 2.32 (s, 3H), 2.25 (s, 3H), 1.18 (t, J = 
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6.9 Hz, 3H) ppm. 13C {1H} NMR (125 MHz, 
DMSO-d6): δ 174.59, 163.25, 159.87 (d, J(C,F) = 
244.7 Hz), 157.32, 154.30, 132.77 (d, J(C,F) = 2.9 
Hz), 130.12 (d, J(C,F) = 8.1 Hz), 124.55, 124.24 
(d, J(C,F) = 2.9 Hz), 121.96, 121.09 (d, J(C,F) = 16.4 
Hz), 116.42, 115.42 (d, J(C,F) = 22.0 Hz), 115.12, 
111.39, 67.19, 65.29, 18.97, 15.13, 8.52 ppm. 19F 
{1H} NMR (470 MHz, DMSO-d6): δ -113.4 
ppm. MS (APCI): calcd for C20H20FO4+ [M+H]+: 
343.1 m/z, found: 343.2 m/z. 
3-(2-Fluorophenyl)-2,9,9,12-tetramethyl-
6,8,9,10-tetrahydro-4H,7H-pyrano[3,2-
b]xanthene-4,7-dione (10). To a solution of 340 
mg (1 mmol) compound 3b 209 mg (1.25 mmol) 
of 3-(N,N-dimethylamino)-5,5-
dimethylcyclohex-2-en-1-one [18] (9) in 10 mL 
of DMF was added. The solution was refluxed 
for 4 h, diluted with 20 mL of methanol, the 
formed precipitate was filtered off and 
recrystallized from DMF-methanol to afford 
compound 10. Yield: 201 mg (48%); white solid; 
m.p. 249 – 250 oC. 1H NMR (400 MHz, CDCl3): 
δ 7.88 (s, 1H), 7.41 – 7.34 (m, 1H), 7.31 – 7.26 
(m, 1H), 7.25 – 7.19 (m, 1H), 7.18 – 7.12 (m, 
1H), 3.61 (s, 2H), 2.52 (s, 2H), 2.40 (s, 3H), 2.35 
(s, 2H), 2.32 (s, 3H), 1.16 (s, 6H) ppm. 13C {1H} 
NMR (100 MHz, CDCl3): δ 197.70, 175.81, 
164.23, 164.05, 160.33 (d, J(C,F) = 246.5 Hz), 
153.76, 151.53, 132.67 (d, J(C,F) = 3.2 Hz), 
130.15 (d, J(C,F) = 8.0 Hz), 124.20, 124.16 (d, 
J(C,F) = 3.3 Hz), 120.74 (d, J(C,F) = 16.3 Hz), 
119.69, 118.71, 117.45, 115.88 (d, J(C,F) = 22.2 
Hz), 113.97, 109.27, 50.73, 41.41, 32.31, 28.58 
(d, J(C,F) = 2.7 Hz), 21.08, 19.51, 8.46 ppm. 19F 
{1H} NMR (376 MHz, CDCl3): δ -114.2 ppm. 
MS (APCI): calcd for C26H24FO4+ [M+H]+: 
419.2 m/z, found: 419.2 m/z. 
6-[(5-Amino-1,3-dimethyl-1H-pyrazol-4-
yl)methyl]-3-(2-fluorophenyl)-7-hydroxy-8-
methyl-4H-chromen-4-one (12). To a solution 
of 314 mg (1 mmol) of compound 6a 223 mg (2 
mmol) of 5-amino-1,3-dimethylpyrazole in 10 
mL of DMF was added. The solution was 
refluxed for 4 h. Then, the mixture was diluted 
with 20 mL of methanol, the formed precipitate 
was filtered off and recrystallized from DMF-
methanol to afford compound 12. Yield: 177 mg, 
(45%); white solid; m.p. 265 – 267 oC. 1H NMR 
(400 MHz, DMSO-d6): δ 9.77 (s, 1H), 8.41 (s, 
1H), 7.44 (s, 1H), 7.43 – 7.37 (m, 2H), 7.30 – 
7.21 (m, 2H), 4.93 (s, 2H), 3.61 (s, 2H), 3.48 (s, 
3H), 2.33 (s, 3H), 1.83 (s, 3H) ppm. 13C {1H} 
NMR (100 MHz, DMSO-d6): δ 174.01, 160.05 
(d, J(C,F) = 246.3 Hz), 157.91, 154.50, 153.94, 
144.54, 144.22, 132.19 (d, J(C,F) = 3.3 Hz), 
130.11 (d, J(C,F) = 8.2 Hz), 127.95, 124.13 (d, 
J(C,F) = 3.3 Hz), 121.80, 120.18 (d, J(C,F) = 15.7 
Hz), 119.10, 116.27, 115.36 (d, J(C,F) = 21.9 Hz), 
111.20, 96.56, 33.95, 22.69, 12.13, 8.75 ppm. 19F 
{1H} NMR (470 MHz, DMSO-d6): δ -113.6 
ppm. MS (APCI): calcd for C22H21FN3O3+ 
[M+H]+: 394.2 m/z, found: 394.2 m/z. 
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